Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been recently diagnosed with ALS (also known as Lou Gehrig's disease), confirmed by your doctor using standard diagnostic guidelines.
- You are being seen and monitored at one of the participating ALS specialist centres — seven located in France and two in Germany.
- You are willing and able to sign a consent form agreeing to take part in the study.
- You are an adult aged 18 years or older.
Who may not be able to join:
- You are unable to understand what the study involves and what would be required of you.
- You are not able to understand or sign the consent form due to cognitive difficulties.
- You are unwilling to take Riluzole (a standard ALS medication) as part of your treatment during the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Philippe COURATIER, Professor, University Hospital, Limoges
Phone: 05 55 05 15 69
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.